台股 » 易威 » 個股財報 » 每月營收

易威

(1799)
  • 股價
    84.9
  • 漲跌
    ▼6.9
  • 漲幅
    -7.52%
  • 成交量
    828
  • 產業
    上櫃 生技醫療類股 ▲0.18%
  • 本地時間:13:30

    68人加入追蹤

    立即追蹤

易威 (1799) 財務報表-每月營收
月營收報表

因應IFRSs國際會計準則,本報表在2013年以前為「個別營收」,2013年以後為「合併營收」。

易威 (1799) 月營收分析比較圖

易威 (1799) 月營收報表

年度/月份營業收入(單位:千元)累計營業收入(單位:千元)
單月營收去年同月營收單月月增率單月年增率累計營收去年累計營收累積年增率
2024/0967,03145,11128.8%48.6%386,770174,590121.5%
2024/0852,03012,809-27.1%306.2%319,739129,479146.9%
2024/0771,40510,23016.3%598%267,709116,670129.4%
2024/0661,38535,76566.5%71.6%196,304106,44084.4%
2024/0536,87113,53049.7%172.5%134,91970,67590.9%
2024/0424,63120,178-49.3%22.1%98,04857,14571.6%
2024/0348,58613,631240.5%256.4%73,41836,96798.6%
2024/0214,26910,48135.1%36.1%24,83223,3366.4%
2024/0110,56312,855-84.4%-17.8%10,56312,855-17.8%
2023/1267,65617,509892.9%286.4%271,628178,89751.8%
2023/116,81429,039-69.8%-76.5%203,972161,38926.4%
2023/1022,56820,301-50%11.2%197,158132,34949%
2023/0945,11118,013252.2%150.4%174,590112,04955.8%
2023/0812,8095,41925.2%136.4%129,47994,03637.7%
2023/0710,23018,627-71.4%-45.1%116,67088,61831.6%
2023/0635,76520,362164.3%75.6%106,44069,99152.1%
2023/0513,5309,336-32.9%44.9%70,67549,62942.4%
2023/0420,1785,22248%286.4%57,14540,29241.8%
2023/0313,63116,70430%-18.4%36,96735,0715.4%
2023/0210,4817,647-18.5%37.1%23,33618,36727%
2023/0112,85510,719-26.6%19.9%12,85510,71919.9%
2022/1217,5097,308-39.7%139.6%178,897197,277-9.3%
2022/1129,03920,47943%41.8%161,389189,969-15%
2022/1020,3019,31212.7%118%132,349169,490-21.9%
2022/0918,0138,467232.4%112.7%112,049160,178-30%
2022/085,41917,148-70.9%-68.4%94,036151,711-38%
2022/0718,62716,399-8.5%13.6%88,618134,563-34.1%
2022/0620,3627,609118.1%167.6%69,991118,164-40.8%
2022/059,33626,32678.8%-64.5%49,629110,555-55.1%
2022/045,22212,589-68.7%-58.5%40,29284,228-52.2%
2022/0316,70443,040118.4%-61.2%35,07171,639-51%
2022/027,64713,748-28.6%-44.4%18,36728,599-35.8%
2022/0110,71914,85246.7%-27.8%10,71914,852-27.8%
2021/127,30834,553-64.3%-78.8%197,277267,654-26.3%
2021/1120,47921,320119.9%-3.9%189,969233,101-18.5%
2021/109,31231,03410%-70%169,490211,781-20%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音